Trial · NCT02134314
Outcomes13
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Patients Enrolled With Serum Creatinine >3mg/dL on Postoperative Day 5. | First 7 days post-transplant | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Number of Patients Enrolled Who Require at Least One Session of Dialysis in the First 7 Days Post Transplant. | First 7 days post-transplant | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Number of Patients With Serum Creatinine Reduction Ratio of < 30% From 24 to 48 Hours Post-transplant. | First 7 days post-transplant | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Number of Dialysis Sessions Per Patient in the First 7 Days Post Transplant. | First 7 days post-transplant | dialysis sessions | MEAN | |
| SECONDARY | Serum Creatinine | Up to 90 days post-transplant | mg/dL | MEAN | |
| SECONDARY | Creatinine Clearance | Up to 90 days post-transplant | ml/minute | MEAN | |
| SECONDARY | 24h Urine Output | 24 hours post-transplant | milliliters | MEAN | |
| SECONDARY | Mean Number of Patients on Dialysis | 15 to 30 days post-transplantation | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Patients With Delayed Graft Function (DGF) (Categorized by DGF Scale) | First 7 days post-transplant | Participants | COUNT_OF_PARTICIPANTS | |
| OTHER_PRE_SPECIFIED | Overall Incidence of Serious Adverse Events | Up to 9 months post-transplant | events | NUMBER | |
| OTHER_PRE_SPECIFIED | Patient Survival | Up to 90 days post-transplant | Participants | COUNT_OF_PARTICIPANTS | |
| OTHER_PRE_SPECIFIED | Rate of Acute Cellular Rejection (ACR) | Up to 90 days post-transplant | episodes | NUMBER | |
| OTHER_PRE_SPECIFIED | Graft Survival | Day 90 Post-transplant | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02134314/outcomes